Welcome to Varian’s Investor Relations Site

Our Mission is to Focus Energy on Saving Lives.

Varian releases 2014 Sustainability Report.

Read more >>

Varian’s Senior Management Team

Moataz Karmalawy, Kolleen Kennedy, Dow Wilson, Elisha Finney, Sunny Sanyal (Left to Right)

Varian’s Imaging Components business is the world’s premier independent supplier of X-ray tubes, flat-panel detectors and workstations for filmless X-ray imaging. Its products are used in X-ray imaging equipment for medical diagnostics, dentistry, veterinary care, industrial inspection, and security. This business also supplies high-energy X-ray technology for cargo screening.

Varian’s “Other” category includes Varian Particle Therapy, which is equipping proton therapy centers with the ProBeam™ therapy system for advanced proton radiotherapy treatments, and the Ginzton Technology Center, which conducts research and development projects in support of improving X-ray imaging and medical care.

Varian’s Oncology Systems business is the world’s leading supplier of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. Its products include linear accelerators, simulators, afterloaders, and a broad range of accessories and interconnected software tools for planning, verifying, and delivering leading-edge treatments in the fight against cancer and other diseases.

Welcome to Varian’s Investor Relations site. As the world leader in radiation oncology treatment systems and software, Varian has pioneered advances in fast and precise radiotherapy, radiosurgery, brachytherapy, and proton therapy treatments for cancer and other indications. Through decades of expertise in advanced X-ray  technologies, Varian is also one of the world’s leading independent suppliers of X-ray tubes and digital image detectors. Since the spin-off off of two other companies in 1999, Varian Medical Systems has grown revenues six-fold and doubled its return on sales. By investing an average of between 6 and 7 percent of sales in research and development each year, Varian is committed to enhancing the effectiveness of its products and services, driving steady growth in all its businesses, and fulfilling its goal of helping to save millions of lives worldwide.

Investor Highlights

Varian Year End Review​

Access the webcast

View the presentation

2013 Annual Report

See Varian’s 2013 Annual Report, with CEO Dow Wilson's description of five strategic initiatives designed to contribute to the company's ongoing growth: Innovation, Globalization, Service and Software, Commercializing Protons, and Operational Excellence.

Price Data
NYSEVAR
Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5834
Fax: 650-424-6822
E-mail: investors@varian.com

Follow Varian Medical Systems on TwitterFollow us on Twitter

Quick Links

2013 Proxy Statement - PDF

Supplement To Proxy Statement For 2014 Annual Meeting Of Stockholders To Be Held On Thursday, February 20, 2014 - PDF

2013 Annual Report - PDF

Online Delivery of Stockholder Materials

Varian Sustainability Report

Transfer Agent

Computershare Trust Company, N.A.
PO Box 43078
Providence, RI 02940-3078
800 756 8200
Hearing impaired: 800 952 9245
www.computershare.com